Attempts to define selective serotonin reuptake inhibitor (SSRI) withdrawal with the term
'discontinuation syndrome'are not supported by evidence. Acknowledging that SSRI use can …

Background: Selective serotonin reuptake inhibitors (SSRI) are widely used in medical
practice. They have been associated with a broad range of symptoms, whose clinical …

Guy Chouinard a, b Virginie-Anne Chouinard c aClinical Pharmacology and Toxicology
Program, Departments of Psychiatry and Medicine, McGill University, and bUniversity Mental …

A characteristic selective serotonin reuptake inhibitor (SSRI) discontinuation syndrome
appears to exist. It is usually mild, commences within 1 week of stopping treatment, resolves …

Adverse events following discontinuation from serotonin reuptake inhibitors (SRIs) are being
reportedin the literature with increasing frequency; the frequency and severity of these …

Adverse events following discontinuation from serotonin reuptake inhibitors (SRIs) are being
reported in the literature with increasing frequency; the frequency and severity of these …

BackgroundAbrupt interruption of therapy with selective serotonin reuptake inhibitors
(SSRIs) has been associated with somatic and psychological symptoms. AimsSystematically …

Objective Tapering of selective serotonin reuptake inhibitor (SSRI) therapy, as opposed to
abrupt discontinuation, has been recommended by several guidelines and in the literature in …

Data on discontinuation phenomena associated with serotonin selective reuptake inhibitors
(SSRIs) are derived primarily from (1) published case reports,(2) data bases of adverse drug …

1We have addressed the question of whether there is a 'serotonin withdrawal syndrome'by
analysis of spontaneous reports of suspected adverse drug reactions (ADRs) associated …